Docetaxel is a key chemotherapeutic agent for treating locally advanced or metastatic breast cancer, but its effectiveness is often hindered by metabolic inactivation from drug-metabolizing enzymes, leading to multidrug resistance (MDR). This study aims to investigate the anti-metastatic effects of combining kaempferol, a flavonoid known for its anticancer properties, with docetaxel in both 2D and […]
Read More